Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

NCT04838639 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: NO-13065
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Factory, Inc.

Collaborators

[object Object]